AAN Issues First Guidelines for Diagnosing and Managing Functional seizures
Functional seizures, often misdiagnosed and poorly understood, now have their first-ever clinical practice guideline released by the American Academy of neurology (AAN). The guideline, published on Thursday, aims to standardize diagnosis and treatment, improving care for the estimated 2-3 per 1,000 people affected by these neurological conditions.This represents a pivotal moment in recognizing and addressing a condition frequently overshadowed by epileptic seizures.
Seizures
Functional seizures – also known as psychogenic non-epileptic seizures (PNES) – are events that look like epileptic seizures but are not caused by abnormal electrical activity in the brain.Rather, they are considered a manifestation of psychological distress, frequently enough linked to trauma, anxiety, or depression.Despite their psychological origins, the physical experience of a functional seizure is very real and can include convulsions, loss of consciousness, and injury.
A key challenge in managing functional seizures has been the lack of clear diagnostic criteria and treatment protocols. This has led to delays in diagnosis, inappropriate treatment with anti-epileptic drugs (which are ineffective for functional seizures), and important patient suffering.
New Diagnostic Recommendations
The AAN guideline emphasizes a extensive diagnostic process. This includes:
- Video-EEG monitoring: This is considered the gold standard for differentiating functional seizures from epileptic seizures. It simultaneously records brain activity (EEG) and the patient’s movements (video) during an event.
- Detailed clinical history: Gathering information about the patient’s psychological history, trauma, and stressors is crucial.
- Neurological examination: A thorough neurological exam helps rule out other potential causes of seizure-like activity.
- Psychological assessment: Evaluating for underlying mental health conditions is essential.
“Accurate diagnosis is the cornerstone of effective management,” stated a senior official involved in the guideline’s advancement. “Distinguishing functional seizures from epilepsy is critical to avoid unneeded medication and to focus on appropriate therapies.”
Treatment Strategies Outlined in the Guideline
The guideline recommends a multidisciplinary approach to treatment, focusing on addressing the underlying psychological factors contributing to the seizures. Key treatment components include:
- Psychotherapy: Cognitive behavioral therapy (CBT) and trauma-focused therapy are considered first-line treatments. These therapies help patients develop coping mechanisms for stress, process traumatic experiences, and modify maladaptive thought patterns.
- Neurologist involvement: While psychotherapy is central, ongoing monitoring and support from a neurologist are vital.
- Collaboration with mental health professionals: A team approach involving psychiatrists, psychologists, and other mental health providers is often necessary.
- Avoiding anti-epileptic drugs: The guideline strongly advises against the routine use of anti-epileptic drugs, as they have not been shown to be effective for functional seizures and can have adverse side effects.
Addressing Stigma and Improving Care
One of the significant barriers to effective care for functional seizures is the stigma associated with the condition.Patients might potentially be wrongly accused of faking their symptoms, leading to feelings of shame and isolation. The AAN guideline aims to raise awareness about functional seizures and promote a more compassionate and understanding approach to care.
“Ther’s a real need to destigmatize these conditions,” noted one analyst. “Patients need to feel safe and supported in seeking help, and healthcare providers need to be educated about the appropriate diagnostic and treatment approaches.”
The release of these guidelines marks a pivotal moment in the understanding and management of functional seizures. By providing clear recommendations for diagnosis and treatment, the AAN hopes to improve the lives of individuals affected by this often-misunderstood neurological condition. Further research is needed to refine treatment strategies and develop new interventions,but this guideline provides a solid foundation for future progress.
